Schizophrenia

Showing NaN - NaN of 132

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Schizophrenia Trial in Worldwide (BI 425809, Placebo)

Recruiting
  • Schizophrenia
  • Garden Grove, California
  • +102 more
Jan 27, 2023

Schizophrenia Trial in Bentonville, Sherman Oaks, Chicago (CVL-231 15 mg, Required CVL-231 30 mg, Placebo)

Recruiting
  • Schizophrenia
  • CVL-231 15 mg
  • +2 more
  • Bentonville, Arkansas
  • +12 more
Jan 27, 2023

Schizophrenia Trial in United States (Placebo, Valbenazine)

Recruiting
  • Schizophrenia
  • Phoenix, Arizona
  • +40 more
Jan 20, 2023

Schizophrenia Trial in United States (Xanomeline and Trospium Chloride Capsules)

Recruiting
  • Schizophrenia
  • Xanomeline and Trospium Chloride Capsules
  • Little Rock, Arkansas
  • +52 more
Jan 17, 2023

Schizophrenia Trial in Worldwide (SEP-363856 50mg, SEP-363856 75mg, Placebo)

Recruiting
  • Schizophrenia
  • SEP-363856 50mg
  • +2 more
  • Little Rock, Arkansas
  • +58 more
Dec 12, 2022

Schizophrenia, Schizophrenia; Psychosis Trial in Ukraine, United States (Xanomeline and Trospium Chloride Capsules, Placebo)

Recruiting
  • Schizophrenia
  • Schizophrenia; Psychosis
  • Xanomeline and Trospium Chloride Capsules
  • Placebo
  • Bentonville, Arkansas
  • +28 more
Aug 12, 2022

Schizophrenia, Bipolar I Disorder, Autism Spectrum Disorder (ASD) Trial in Puerto Rico, United States (Cariprazine Flexible

Recruiting
  • Schizophrenia
  • +2 more
  • Cariprazine Flexible Dose
  • Dothan, Alabama
  • +32 more
Aug 8, 2022

Blood Pressure, Schizophrenia Trial in United States (CVL-231)

Active, not recruiting
  • Blood Pressure
  • Schizophrenia
  • Bentonville, Arkansas
  • +9 more
Jul 11, 2022

Schizophrenia Trial in Worldwide (BI 409306, Placebo)

Terminated
  • Schizophrenia
  • BI 409306
  • Placebo
  • Phoenix, Arizona
  • +58 more
Apr 19, 2022

Schizophrenia Trial in United States (ASP4345, , risperidone)

Completed
  • Schizophrenia
  • Cerritos, California
  • +26 more
Apr 14, 2022

Schizophrenia Trial in United States (Brilaroxazine, Placebo)

Recruiting
  • Schizophrenia
  • Phoenix, Arizona
  • +17 more
Apr 1, 2022

Long Acting Injectable Medications in Schizophrenia

Active, not recruiting
  • Schizophrenia
    • Tucson, Arizona
    • +56 more
    Feb 10, 2022

    Schizophrenia, Schizophreniform Disorder, Bipolar I Disorder Trial in Worldwide (ALKS 3831)

    Active, not recruiting
    • Schizophrenia
    • +2 more
    • ALKS 3831
    • Little Rock, Arkansas
    • +85 more
    Feb 10, 2022

    Schizophrenia Trial in United States (CTP-692, Placebo)

    Completed
    • Schizophrenia
    • Little Rock, Arkansas
    • +23 more
    Dec 13, 2021

    Schizophrenia Trial in Worldwide (Luvadaxistat, Placebo)

    Completed
    • Schizophrenia
    • Garden Grove, California
    • +53 more
    Dec 7, 2021

    Schizophrenia, Alcohol Use Disorder Trial in Bulgaria, Poland, United States (Samidorphan + olanzapine (ALKS 3831), Placebo +

    Completed
    • Schizophrenia
    • Alcohol Use Disorder
    • Samidorphan + olanzapine (ALKS 3831)
    • Placebo + olanzapine
    • Little Rock, Arkansas
    • +70 more
    Sep 14, 2021

    Schizophrenia Trial in Bulgaria, Czechia, United States (Samidorphan (Low Dose), Samidorphan (Medium Dose), Samidorphan (High

    Completed
    • Schizophrenia
    • Samidorphan (Low Dose)
    • +4 more
    • Little Rock, Arkansas
    • +60 more
    Sep 10, 2021

    Schizophrenia Trial in United States (Abilify MyCite®)

    Terminated
    • Schizophrenia
    • Abilify MyCite®
    • Phoenix, Arizona
    • +67 more
    Aug 10, 2021

    Schizophrenia Trial in Puerto Rico, United States (ALKS 3831)

    Completed
    • Schizophrenia
    • ALKS 3831
    • Little Rock, Arkansas
    • +44 more
    Jul 20, 2021

    Schizophrenia, Bipolar I Disorder Trial in United States (Aripiprazole)

    Completed
    • Schizophrenia
    • Bipolar I Disorder
    • Little Rock, Arkansas
    • +18 more
    Jun 16, 2021

    Schizophrenia Trial in Austin (1 Hz rTMS, 10 Hz rTMS)

    Terminated
    • Schizophrenia
    • 1 Hz rTMS
    • 10 Hz rTMS
    • Austin, Texas
      Seton Brain and Spine Institute "Brain Stimulation Laboratory"
    Mar 16, 2021

    Schizophrenia Trial in United States (SEP363856 150 mg, Placebo, moxifloxacin 400 mg)

    Completed
    • Schizophrenia
    • SEP363856 150 mg
    • +2 more
    • Little Rock, Arkansas
    • +6 more
    Nov 30, 2020

    Schizophrenia Trial in Worldwide (Lu AF35700)

    Completed
    • Schizophrenia
    • Lu AF35700
    • Bellflower, California
    • +101 more
    Sep 30, 2020

    Schizophrenia Trial in United States (Xanomeline and Trospium Chloride Capsules, Placebo Capsules)

    Completed
    • Schizophrenia
    • Xanomeline and Trospium Chloride Capsules
    • Placebo Capsules
    • Little Rock, Arkansas
    • +11 more
    Oct 1, 2020

    Schizophrenia, Bipolar I Disorder Trial in United States (Aripiprazole)

    Completed
    • Schizophrenia
    • Bipolar I Disorder
    • Little Rock, Arkansas
    • +3 more
    Aug 31, 2020